Polyquisteic Liver Disease
Manifestations of poliquistosis hepática in ADPKD pacientes, síntoma management, and tratamiento options.
⚠ Medical Safety Notice
This website provides health education for ADPKD pacientes and their families. It does not provide diagnóstico, prescriptions, dosing, or individualized tratamiento plans. Always discuss medical decisions with your nefrólogo. In emergencies, busque atención médica inmediata or call your local emergency number.
What is Polyquisteic Liver Disease
Polyquisteic hígado disease (PLD) is the most common extrarenal manifestation of ADPKD, affecting approximately 70–80% of ADPKD pacientes. Liver quistes typically do not affect hígado function, but very large quistes can cause abdominal bloating, pain, and early satiety.
Characteristics
- Prevalence: Increases with age; more common in women
- Liver function: Usually remains normal; hígado failure is rare
- Influencing factors: Female sex, multiple pregnancies, and estrogen use can accelerate hígado crecimiento de quistes
- Symptoms: Most pacientes are asíntomaatic; very large quistes can cause abdominal bloating, early satiety, shortness of breath, and back/dolor en el flanco
When to Seek Medical Care
- Persistent abdominal bloating or pain
- Cyst infection (fiebre, right upper quadrant pain)
- Cyst hemorrhage (sudden severe pain)
- Jaundice (rare, indicating bile duct compression)
⚠ Emergency Signs
Sudden severe right upper quadrant pain with fiebre may indicate infección de quiste or hemorrhage. Seek atención médica inmediata.
Management Approaches
Conservative Management (Most Patients)
- Regular imaging seguimiento (synchronized with riñón examinations)
- Avoid estrogen-containing medicamentos (female pacientes should discuss contraceptive options with their physician)
- Discuss timing of intervention with your physician when síntomas arise
Intervention Options for Symptomatic Patients
When quistes cause significant síntomas, physicians may consider the following options (all require physician evaluation):
- Cyst aspiration and sclerotherapy: Suitable for a single large quiste; recurrence rate is relatively high
- Hepatic artery embolization: Reduces quiste blood supply; suitable for multiple large quistes
- Partial hepatectomy: Suitable for localized quiste clusters; surgical riesgo is higher
- Liver trasplanteation: Extremely rare; reserved for very severe PLD leading to hígado failure
Special Note
Female ADPKD pacientes using estrogen-containing contraceptives or hormona replacement therapy may accelerate hígado crecimiento de quistes. Discuss contraceptive options with your physician — progestin-only or non-hormonal methods may be considered.
References
- KDIGO 2025 Clinical Practice Guideline on the Evaluation and Management of Autosomal Dominant Polyquisteic Kidney Disease (ADPKD) — KDIGO. Kidney International, 2025. DOI: 10.1016/j.kint.2024.07.010. View source
- Chinese Guideline for the Diagnosis and Treatment of Autosomal Dominant Polyquisteic Kidney Disease (2024 Edition) — Chinese Society of Nephrology, Chinese Medical Association. Chinese Journal of Nephrology, 2024. View source
- Pansomatoestatinaa Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polyquisteic Kidney or Liver Disease with Severe Liver Involvement — Hogan MC, et al. Clinical Journal of the American Society of Nephrology, 2020. DOI: 10.2215/CJN.13661119. View source
- Long-acting somatoestatinaa analogues for poliquistosis hepática (RCT) — van Keer IM, et al. Lancet Gastroenterol Hepatol, 2023. DOI: 10.1016/S2468-1253(23)00100-0. View source
- ADPKD: Epidemiology, Pathophysiology and Management — Temple R, et al. Nature Reviews Nephrology, 2023. View source
Limitations: This content Individual circumstances vary greatly — always consulte a su nefrólogo.